Your browser doesn't support javascript.
loading
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Boku, N; Ryu, M-H; Kato, K; Chung, H C; Minashi, K; Lee, K-W; Cho, H; Kang, W K; Komatsu, Y; Tsuda, M; Yamaguchi, K; Hara, H; Fumita, S; Azuma, M; Chen, L-T; Kang, Y-K.
Afiliación
  • Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kato K; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Chung HC; Department of Medical Oncology, Yonsei Cancer Center, Song Dang Institute for Cancer Research, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.
  • Minashi K; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Lee KW; Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Cho H; Department of Surgery, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan (previously Kanagawa Cancer Center, Yokohama, Japan.
  • Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Komatsu Y; Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan.
  • Tsuda M; Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
  • Yamaguchi K; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hara H; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Fumita S; Department of Medical Oncology, Nara Hospital Kindai University, Ikoma, Japan.
  • Azuma M; Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
  • Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: ykkang@amc.seoul.kr.
Ann Oncol ; 30(2): 250-258, 2019 02 01.
Article en En | MEDLINE | ID: mdl-30566590
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Unión Esofagogástrica / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Unión Esofagogástrica / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article